Predicting and Responding to Emerging Viral Infections
Oct 13–16, 2025 | Crowne Plaza Geneva, Geneva, Switzerland
Scientific Organizers:
Suresh Mahalingam, Christopher F. Basler, Felicity Burt, and Alina Baum
In Person
On Demand
×
-
Oct 13–16, 2025 | Crowne Plaza Geneva, Geneva, Switzerland
Scientific Organizers: Suresh Mahalingam, Christopher F. Basler, Felicity Burt, and Alina Baum
Suresh Mahalingam
Christopher F. Basler
Felicity Burt
Alina Baum
Available Formats:
Supported by:
In Person
On Demand
***Meeting program subject to change.
Available Formats: = In Person = On DemandMonday, October 13, 2025
Fundraising
Booking Function
Merchandise Options
Registration Options
Registration
4:00–8:00 PM
Foyer International
Welcome Mixer
6:00–8:00 PM
Foyer International
Tuesday, October 14, 2025
Breakfast
7:30–8:30 AM
Individual Hotel
Coffee Available
8:00–8:30 AM
Foyer International
Poster Setup
8:05–8:30 AM
Londres Ballroom
Poster Viewing
8:15–5:00 PM
Londres Ballroom
Welcome and Keynote Address
8:30–9:30 AM
New York Ballroom
Maria D. Van Kerkhove, World Health Organization
Remote Presentation: Preparing For the Next Pandemic in Increasingly Complex Times
Remote Presentation: Preparing For the Next Pandemic in Increasingly Complex Times
Why Should I Trust You? Podcast Introduction
9:30–9:40 AM
New York Ballroom
Predictive Modeling and Surveillance
9:40–11:45 AM
New York Ballroom
Bethan Purse, UK Centre for Ecology & Hydrology
Environmental Change and Drivers of Emergence of Vector-Borne Viruses
Environmental Change and Drivers of Emergence of Vector-Borne Viruses
Yee-Sin LEO, National Centre for Infectious Diseases
Virus Surveillance and Predictive Modeling: Insights from Singapore's Public Health Interventions
Virus Surveillance and Predictive Modeling: Insights from Singapore's Public Health Interventions
Felicity Burt, University of The Free State
Diagnosis and Surveillance of Emerging Arboviruses in Africa
Diagnosis and Surveillance of Emerging Arboviruses in Africa
Coffee Break
10:00–10:20 AM
Foyer International
Lunch
11:45–12:45 PM
Zurich Ballroom
Poster Session 1
12:30–2:30 PM
Londres Ballroom
Symposia Spotlight 1: Transformative Strategies for Viral Discovery, Diagnosis, Prediction & Response
2:30–4:30 PM
New York Ballroom
John K Wickiser, Columbia University
The Use of Pathogen-Focused Metagenomics Strategies Within the Diagnostic Network Interrogating Both Clinical and Environmental Samples for Surveillance and Discovery
The Use of Pathogen-Focused Metagenomics Strategies Within the Diagnostic Network Interrogating Both Clinical and Environmental Samples for Surveillance and Discovery
Debora Marks, Harvard Medical School
How AI Can Help Predict Viral Evolution to Accelerate Vaccine and Therapeutic Design
How AI Can Help Predict Viral Evolution to Accelerate Vaccine and Therapeutic Design
Kirsty Short, University of Queensland
The Host Response as a Novel Diagnostic Biomarker for ‘Pre-positive’ Viral Infection
The Host Response as a Novel Diagnostic Biomarker for ‘Pre-positive’ Viral Infection
Tristan Russell, UCD
Development of Metagenomic Next Generation Sequencing for the Discovery and Surveillance of Emerging and Reemerging Viruses in Ireland
Development of Metagenomic Next Generation Sequencing for the Discovery and Surveillance of Emerging and Reemerging Viruses in Ireland
Aarushi Mehrotra, Harvard Medical School
Forecasting H1N1 Influenza Pandemic and Seasonal Evolution
Forecasting H1N1 Influenza Pandemic and Seasonal Evolution
Carol de Souza Moreira, University of Notre Dame
Bayesian Latent Class Modeling to Assess Diagnostic Accuracy of Dengue, Zika, And Chikungunya Tests Across Multi-Country Studies
Bayesian Latent Class Modeling to Assess Diagnostic Accuracy of Dengue, Zika, And Chikungunya Tests Across Multi-Country Studies
Coffee Available
4:30–5:00 PM
Foyer International
Pandemic Preparedness and Response Strategies
5:00–7:00 PM
New York Ballroom
Pei-Yong Shi, GSK
GSK's Role in Strengthening Pandemic Preparedness
GSK's Role in Strengthening Pandemic Preparedness
Rick Arthur Bright, Bright Global Health
Detecting and Responding to Emerging Viral Infections
Detecting and Responding to Emerging Viral Infections
Hassan Ajulo, James Cook University
Short Talk: Spatiotemporal Modelling and Composite Indices for Pandemic Preparedness: A Novel Geospatial-Temporal Approach
Short Talk: Spatiotemporal Modelling and Composite Indices for Pandemic Preparedness: A Novel Geospatial-Temporal Approach
On Own for Dinner
7:00–8:00 PM
Wednesday, October 15, 2025
Breakfast
7:30–8:30 AM
Individual Hotel
Coffee Available
8:00–8:30 AM
Foyer International
Poster Setup
8:05–8:30 AM
Londres Ballroom
Poster Viewing
8:15–5:00 PM
Londres Ballroom
Keynote Address
8:30–9:30 AM
New York Ballroom
Richard Hatchett, Coalition for Epidemic Preparedness Innovations, CEPI
The Future of Pandemic Preparedness
The Future of Pandemic Preparedness
Coffee Break
9:30–9:50 AM
Foyer International
Award Recipient Acknowledgement
9:50–9:55 AM
New York Ballroom
Vaccines
9:50–11:50 AM
New York Ballroom
Regis Gervier †, Sanofi US
Talk Title to be Announced
Talk Title to be Announced
Andrea Marzi, NIAID, National Institutes of Health
Current Filovirus Vaccine Candidates – Focus on VSV-based Vaccines
Current Filovirus Vaccine Candidates – Focus on VSV-based Vaccines
George Warimwe, University of Oxford
Combating Rift Valley Fever - ChAdOx1 Rift Valley Fever Vaccine Safety and Immunogenicity: Phase 1 Trial in Adults
Combating Rift Valley Fever - ChAdOx1 Rift Valley Fever Vaccine Safety and Immunogenicity: Phase 1 Trial in Adults
Kizzmekia S. Corbett-Helaire, Harvard T.H. Chan School of Public Health
Preparing for a Pandemic: Lessons from COVID Vaccines and Applications to Other Viral Diseases
Preparing for a Pandemic: Lessons from COVID Vaccines and Applications to Other Viral Diseases
Lunch
11:50–12:50 PM
Zurich Ballroom
Poster Session 2
12:30–2:30 PM
Londres Ballroom
Panel Discussion: Scientific Challenges & Research Strategies for Pandemic Preparedness
3:00–4:30 PM
New York Ballroom
Coffee Available
4:30–5:00 PM
Foyer International
Therapeutics
5:00–7:00 PM
New York Ballroom
Laura M Walker, Moderna
Constraining Viral Escape with mRNA-Encoded Engineered Antibodies
Constraining Viral Escape with mRNA-Encoded Engineered Antibodies
Suresh Mahalingam, Griffith University
Advancements in Drug Repurposing and New Therapeutics for Arthritogenic Alphaviruses: Tackling Acute and Chronic Disease
Advancements in Drug Repurposing and New Therapeutics for Arthritogenic Alphaviruses: Tackling Acute and Chronic Disease
Alina Baum, Regeneron Pharmaceuticals
Filovirus Therapeutic Antibodies
Filovirus Therapeutic Antibodies
Guillermo Albericio Bonilla, CNB-CSIC
Short Talk: Plitidepsin as a Novel Antiviral Candidate Against Monkeypox Virus
Short Talk: Plitidepsin as a Novel Antiviral Candidate Against Monkeypox Virus
Walter Reichard, University of Tennessee Health Science Center
Short Talk: Efficacy of the Antiviral, BDGR-49, During Venezuelan Equine Encephalitis Infection of the Emulate Human Brain-Chip
Short Talk: Efficacy of the Antiviral, BDGR-49, During Venezuelan Equine Encephalitis Infection of the Emulate Human Brain-Chip
On Own for Dinner
7:00–8:00 PM
Thursday, October 16, 2025
Breakfast
7:30–8:30 AM
Individual Hotel
Coffee Available
8:00–8:30 AM
Foyer International
Zoonoses 1 - One Health
8:30–11:30 AM
New York Ballroom
Martin Groschup, Friedrich-Loeffler-Institut
Arbovirus and Zoonotic Virus Surveillance in Africa: Emphasizing a One Health Approach
Arbovirus and Zoonotic Virus Surveillance in Africa: Emphasizing a One Health Approach
Ian Brown, The Pirbright Institute
One Health Approach to Avian and Swine Influenza
One Health Approach to Avian and Swine Influenza
Chee Wah Tan, National University of Singapore
Discovery of New Filoviruses/Other Viruses in Bats in Asia
Discovery of New Filoviruses/Other Viruses in Bats in Asia
Scott C. Weaver, University of Texas Medical Branch
Re-emerging Alphaviruses: Chikungunya and Western Equine Encephalitis
Re-emerging Alphaviruses: Chikungunya and Western Equine Encephalitis
Jordan D. Dimitrov, INSERM Centre de Recherche des Cordeliers
Short Talk: System Serology Analyses of Antibody Responses in Bats to Human Pathogens
Short Talk: System Serology Analyses of Antibody Responses in Bats to Human Pathogens
Emma J Grant, La Trobe University
Short Talk: CD8+ T Cell Epitope Conservation in Emerging H5N1 Viruses Suggests Global Protection
Short Talk: CD8+ T Cell Epitope Conservation in Emerging H5N1 Viruses Suggests Global Protection
Coffee Break
9:30–9:50 AM
Foyer International
Lunch: Featuring Women in Pandemic Preparedness
11:30–12:30 PM
Zurich Ballroom
Career Roundtable
1:00–2:00 PM
New York Ballroom
Symposia Spotlight 2: Cutting-edge Countermeasures to Combat Emerging Viral Threats
2:30–4:30 PM
New York Ballroom
Siew-Wai Fong, A*STAR IDL
Immune Modulators in Mosquito Saliva: A New Therapeutic Target to Combat Arboviral Threats
Immune Modulators in Mosquito Saliva: A New Therapeutic Target to Combat Arboviral Threats
Isabella Eckerle, University Hospitals of Geneva and University of Geneva
Modeling Age-Specific Innate Responses to Respiratory Viruses Using Primary Human Airway Epithelial Cells: Implications for Pandemic Preparedness
Modeling Age-Specific Innate Responses to Respiratory Viruses Using Primary Human Airway Epithelial Cells: Implications for Pandemic Preparedness
Nicholas Cheang, National University of Singapore
Intranasal Dendritic Cell-Targeting Vaccine Booster Elicits Cross-Clade, Durable And Protective Systemic And Mucosal Immunity Against Sarbecoviruses Of Pandemic Potential
Intranasal Dendritic Cell-Targeting Vaccine Booster Elicits Cross-Clade, Durable And Protective Systemic And Mucosal Immunity Against Sarbecoviruses Of Pandemic Potential
Meghan Vermillion, Gilead Sciences
Obeldesivir: A Candidate Oral Post-Exposure Prophylaxis for Filovirus Outbreak Control
Obeldesivir: A Candidate Oral Post-Exposure Prophylaxis for Filovirus Outbreak Control
Mathieu Mateo, Institut Pasteur
Preclinical Development of a MOPEVAC Vaccine Against Lassa Fever in Nonhuman Primates
Preclinical Development of a MOPEVAC Vaccine Against Lassa Fever in Nonhuman Primates
Matthew Sutton, Vaccine Research Center, NIAID, NIH
Therapeutic Protection Against Multiple Encephalitic Alphaviruses By A Vaccine-Elicited Pan-Alphavirus Antibody
Therapeutic Protection Against Multiple Encephalitic Alphaviruses By A Vaccine-Elicited Pan-Alphavirus Antibody
Patrick Chun Hean Tang, Griffith University
Development of a Codon-Deoptimized Live-Attenuated Vaccine for Zika Virus: Preclinical Efficacy in Pregnant and Male Mouse Models
Development of a Codon-Deoptimized Live-Attenuated Vaccine for Zika Virus: Preclinical Efficacy in Pregnant and Male Mouse Models
Robert Abbott, University of Texas Medical Branch
Antigen Avidity Drives the Durability of the Vaccine Immune Response
Antigen Avidity Drives the Durability of the Vaccine Immune Response
Coffee Available
4:30–5:00 PM
Foyer International
Zoonoses 2 – Virus-Host Interactions
5:00–6:45 PM
New York Ballroom
Richard J. Webby, St. Jude Children's Research Hospital
An Unexpected Outbreak of H5N1 Influenza in Dairy Cattle
An Unexpected Outbreak of H5N1 Influenza in Dairy Cattle
Geoffrey L. Smith, Shanghai Institute for Immunity and Infection, Chinese Academy of Sciences
Host Restriction of Monkeypox Virus and Viral Evasion Strategies
Host Restriction of Monkeypox Virus and Viral Evasion Strategies
Christopher F. Basler, Icahn School of Medicine, Mt Sinai
Virus-Host Interactions of Filoviruses with a Focus on Ebola and Marburg
Virus-Host Interactions of Filoviruses with a Focus on Ebola and Marburg
Yasuo Ariumi, CCPID, Nagasaki University
Ebola Virus VP35 Hijacks P-body and Stress Granule Components into Inclusion Body
Ebola Virus VP35 Hijacks P-body and Stress Granule Components into Inclusion Body
Meeting Wrap-Up: Outcomes and Future Directions
6:45–7:00 PM
New York Ballroom
On Own for Dinner
7:00–8:00 PM
Friday, October 17, 2025
Departure
12:00–11:59 PM
Subscribe for Updates